Appendix 1: Details of applications reviewed Applications reviewed by full committee Co-ordinating Study reference Study status Short title Other Investigators Locality/ies Application type Investigator A study to evaluate Vx135 Auckland Clinical Studies 13/STH/10 Approve and GSK2336805 in Prof Ed Gane Intervention Ltd,Chris Taylor, CCST Chronic HCV patients. NORIBOGAINE THERAPY Health Research South,Zenith FOR RELIEF OF OPIOID 13/STH/100 Approve Professor Paul Glue Technology Corporation Intervention WITHDRAWAL, PHASE IB Limited (NITROW PIB) Media, advertising and other 13/STH/107 Approve influences on decisions to Ms Henderson Intervention enter aged care CPT-SIOP-2009 Tumours of Auckland District Health 13/STH/11 Approve Dr Robin Paul Corbett Intervention the Choroid Plexus Board,CDHB Research Office Behavioral and Dr Masayuki 13/STH/122 Approve physiological biomarkers for Dr Michael MacAskill Observational Watanabe neurological disorders Sialyl Lewis antigen 13/STH/123 Approve Dr Michael Jameson Observational expression in melanoma 13/STH/124 Approve Reducing FGF23 in CKD Dr. Christopher Hood Dr Samantha Everitt Intervention Quetiapine 1 x 200 mg Zenith Technology bioequivalence study Corporation Limited,Zenith 13/STH/125 Approve conducted under fasting Dr Noelyn Hung Intervention Technology Corporation conditions and at steady Limited state Quetiapine 1 x 50 mg Zenith Technology bioequivalence study Corporation Limited,Zenith 13/STH/126 Approve Dr Noelyn Hung Intervention conducted under fasting Technology Corporation conditions Limited
Appendix 1: Details of applications reviewed Applications reviewed by full committee Study reference Study status Short title Co-ordinating Investigator Other Investigators Locality/ies Application type 13/STH/10 Approve A study to evaluate Vx135 and GSK2336805 in Chronic HCV patients. Prof Ed Gane Auckland Clinical Studies Ltd,Chris Taylor, CCST Intervention 13/STH/100 Approve NORIBOGAINE THERAPY FOR RELIEF OF OPIOID WITHDRAWAL, PHASE IB (NITROW PIB) Professor Paul Glue Health Research South,Zenith Technology Corporation Limited Intervention 13/STH/107 Approve Media, advertising and other influences on decisions to enter aged care Ms Henderson Intervention 13/STH/11 Approve CPT-SIOP-2009 Tumours of the Choroid Plexus Dr Robin Paul Corbett Auckland District Health Board,CDHB Research Office Intervention 13/STH/122 Approve Behavioral and physiological biomarkers for neurological disorders Dr Masayuki Watanabe Dr Michael MacAskill Observational 13/STH/123 Approve Sialyl Lewis antigen expression in melanoma Dr Michael Jameson Observational 13/STH/124 Approve Reducing FGF23 in CKD Dr. Christopher Hood Dr Samantha Everitt Intervention 13/STH/125 Approve Quetiapine 1 x 200 mg bioequivalence study conducted under fasting conditions and at steady state Dr Noelyn Hung Zenith Technology Corporation Limited,Zenith Technology Corporation Limited Intervention 13/STH/126 Approve Quetiapine 1 x 50 mg bioequivalence study conducted under fasting conditions Dr Noelyn Hung Zenith Technology Corporation Limited,Zenith Technology Corporation Limited Intervention
southern-ethics-committee-annual-report-2013.docx